FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


16226 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Cyclopentolate hydrochloride 0.5% single-use eye drops Cyclopentolate hydrochloride 5 mg/mL eye solution
Cyclopentolate hydrochloride 1% conventional release eye drops Cyclopentolate hydrochloride 10 mg/mL eye solution
Cyclopentolate hydrochloride 1% single-use eye drops Cyclopentolate hydrochloride 10 mg/mL eye solution
Cyclopentolate hydrochloride 2% eye drops Cyclopentolate hydrochloride 20 mg/mL eye solution
Cyclophosphamide 1g/vial injection Cyclophosphamide 1 g powder for solution for injection vial
Cyclophosphamide 1g/vial powder for injection Cyclophosphamide 1 g powder for solution for injection vial
Cyclophosphamide 200mg/vial injection Cyclophosphamide 200 mg powder for solution for injection vial
Cyclophosphamide 200mg/vial powder for injection Cyclophosphamide 200 mg powder for solution for injection vial
Cyclophosphamide 2g/vial injection Product containing precisely cyclophosphamide 2 gram/1 vial powder for conventional release solution for injection (clinical drug)
Cyclophosphamide 500mg/vial injection Cyclophosphamide 500 mg powder for solution for injection vial
Cyclophosphamide 500mg/vial powder for injection Cyclophosphamide 500 mg powder for solution for injection vial
Cyclopropane [no agents] Cyclopropane
Cyclosporin 50mg/1mL oily infusion concentrate Product containing precisely ciclosporin 50 milligram/1 milliliter conventional release solution for injection (clinical drug)
Cyclosporine 100mg/5mL solution Product containing only ciclosporin (medicinal product)
Cyclosporine 100mg/mL solution Ciclosporin 100 mg/mL oral solution
Cyclosporine 50mg gel Ciclosporin 50 mg oral capsule
Cyclosporine ophthalmic emulsion 0.05% Product containing precisely ciclosporin 500 microgram/1 milliliter conventional release eye suspension (clinical drug)
Cylindrical cell papilloma uncertain whether benign or malignant Oncocytic Schneiderian papilloma of uncertain behavior (morphologic abnormality)
Cylindrocarpon tonkinense Neocosmospora lichenicola (organism)
Cyproheptadine hydrochloride 2mg/5mL oral syrup Product containing precisely cyproheptadine hydrochloride 400 microgram/1 milliliter conventional release oral solution (clinical drug)
Cyriax's syndrome Tietze's disease (disorder)
Cyst of Bartholin's gland Cyst of Bartholin's gland duct
Cyst of bursa Bursal cyst
Cyst of testes Cyst of testis (disorder)
Cysteamine 0.1% eye drops Product containing precisely mercaptamine 1 milligram/1 milliliter conventional release eye solution (clinical drug)
Cysteine carboxypeptidase Cysteine carboxypeptidase
Cysteine proteinase Cysteine proteinase
Cystic disease Fibrocystic change
Cystoscopic extirpation of bladder lesion NOS Cystoscopy and destruction of lesion of urinary bladder
Cystoscopy: [diagnostic NOS] or [unspecified check] Transurethral cystoscopy (procedure)
Cytarabine 100mg injection (pdr for recon)+diluent Product containing only cytarabine in parenteral dose form (medicinal product form)
Cytarabine 100mg powder for injection solution vial Product containing only cytarabine in parenteral dose form (medicinal product form)
Cytarabine 1g injection (pdr for recon)+diluent Product containing only cytarabine in parenteral dose form (medicinal product form)
Cytarabine 1g powder for injection solution vial Product containing only cytarabine in parenteral dose form (medicinal product form)
Cytochrome p450 CYP2C9 enzyme deficiency Cytochrome P450 family 2 subfamily C member 9 poor metabolizer (finding)
Cytochrome p450 CYP2D6 enzyme deficiency Cytochrome P450 family 2 subfamily D member 6 poor metabolizer (finding)
Cytochrome-b reductase deficiency Dihydrolipoamide dehydrogenase deficiency
Cytology of organ NOC Cytologic test
Cytology of organ NOC NOS Cytologic test
Cytophaga uliginosa Zobellia uliginosa (organism)
Cytotoxic injection NOS Injection
Cytotoxic injection NOS Injection
DF-1 Group Capnocytophaga ochracea
DHSS medical examination NOS Specialized medical examination
DS1500 attendance allowance NOS Attendance allowance medical
DS1500 attendance allowance exam Attendance allowance medical
DS4 attend allowance exam NOS Attendance allowance medical
Dacarbazine 200mg/vial injection Product containing precisely dacarbazine (as dacarbazine citrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Daclizumab 25mg/5 mL solution Daclizumab only product in parenteral dose form
Daclizumab 25mg/5mL conventional release solution for injection Daclizumab only product in parenteral dose form
Daclizumab 25mg/5mL infusion concentrate Daclizumab only product in parenteral dose form
Dacron Polyethylene terephthalate (substance)
Dacryocystorhinostomy and insertion of tube however further qualified Dacryocystorhinostomy and insertion of tube
Dactylaria constricta var constricta Ochroconis constricta
Daily Daily (qualifier value)
Daktarin oral gel 15g Product manufactured as oromucosal dose form (product)
Damaliscus dorcas Damaliscus pygargus (organism)
Damp environment Damp environment
Danaparoid sodium Product containing danaparoid (medicinal product)
Danaparoid sodium adverse reaction Adverse reaction to danaparoid (disorder)
Danaparoid sodium allergy Allergy to danaparoid (finding)
Dance therapy Dance therapy
Dangerous environment Dangerous environment
Dansac two-piece ostomy system Two-piece ostomy system (physical object)
Dantrolene sodium 20mg/vial injection Dantrolene sodium 20 mg powder for solution for injection vial
Darkness tremor Tremor
Darrows infusion solution 1 L bag Product containing only potassium chloride and sodium chloride and sodium lactate (medicinal product)
Darrows infusion solution 500 mL bag Product containing only potassium chloride and sodium chloride and sodium lactate (medicinal product)
Darrows infusion solution bag Product containing only potassium chloride and sodium chloride and sodium lactate (medicinal product)
Daruavir ethanolate Darunavir ethanolate (substance)
Daughter of subject Daughter
De-icer Automotive de-icer (substance)
Deafness (& symptom) Hearing loss
Deafness (& symptom) Hearing loss
Deafness symptom Hearing loss
Debaromyces Debaryomyces
Debaromyces hansenii Debaryomyces hansenii
Debridement of skin or subcutaneous tissue of pacemaker pocket Debridement of pacemaker pocket
Decreased 11-deoxy, 17-hydroxycorticosterone level 11-deoxy, 17-hydroxycorticosterone level below reference range
Decreased 11-deoxycorticosterone level 11-deoxycorticosterone level below reference range (finding)
Decreased 17-ketosteroids level 17-ketosteroids level below reference range (finding)
Decreased Q-T interval Shortened QT interval
Decreased active range of ankle extension Decreased active range of ankle plantar flexion
Decreased active range of ankle flexion Decreased active range of ankle dorsiflexion (finding)
Decreased adrenal cortical hormone level Adrenal cortical hormone level below reference range
Decreased adrenocorticotropic hormone level Adrenocorticotropic hormone level below reference range (finding)
Decreased androgen level Androgen level below reference range
Decreased anti-diuretic hormone level Anti-diuretic hormone level below reference range
Decreased ascorbic acid Ascorbic acid below reference range (finding)
Decreased biotin Biotin below reference range (finding)
Decreased carboxyhemoglobin Carboxyhaemoglobin below reference range
Decreased carotene Carotene below reference range
Decreased corticosterone level Corticosterone level below reference range
Decreased corticotropin releasing factor level Corticotropin releasing factor level below reference range (finding)
Decreased cortisol level Cortisol level below reference range (finding)
Decreased cortisone level Cortisone level below reference range
Decreased cremasteric reflex Decreased cremasteric reflex
Decreased epinephrine level Epinephrine level below reference range (finding)
Decreased estradiol level Oestradiol level below reference range
Decreased estriol level Oestriol level below reference range
Decreased estrone level Oestrone level below reference range

Start Previous Page 32 of 163 Next End


Reference Sets

Reference set descriptor

Back to Start